Skip to main content
MyPeptideMatch logoMyPeptideMatch
Reviewed by MyPeptideMatch Editorial TeamLast reviewed February 2026Updated February 2026

Sermorelin Dosing Protocol: 5 mg Vial — Daily Dosing Schedule & Supplies

Week-by-week subcutaneous dosing schedule for sermorelin GHRH analogue using the 5 mg vial, with reconstitution steps and supplies.

Quickstart highlights

Sermorelin acetate (GHRH 1-29 NH2) is a 29-amino acid analogue of endogenous growth hormone-releasing hormone (GHRH) that binds pituitary GHRH receptors with high affinity, stimulating pulsatile GH release through a physiological mechanism rather than direct GH administration.

  • Concentration: 2 mg/mL (5 mg vial + 2.5 mL bacteriostatic water).
  • At 2 mg/mL: 100 µg = 5 units, 200 µg = 10 units, 300 µg = 15 units, 500 µg = 25 units.
  • Inject nightly 30–60 minutes before sleep; avoid high-glycemic food 2 hours before.
  • One 5 mg vial provides 25 nightly doses at 200 µg or ~17 doses at 300 µg.
  • Combine with ipamorelin or GHRP-2 for synergistic GH secretion via complementary receptors.

Dosing table

For educational reference only. Your prescribing provider may adjust doses based on your clinical profile and response.

WeekDose (µg)UnitsFrequencyNotes
1-420010Once daily (before bed)200 µg nightly — 10 units; one 5 mg vial provides 25 nightly doses
5-1230015Once daily (before bed)300 µg — 15 units; often combined with GHRP (ipamorelin/GHRP-2) for synergy
13+50025Once daily (before bed)500 µg maintenance — 25 units; maximum clinical dose in most protocols

Gradual approach

WeekDose (µg)UnitsNotes
1-81005100 µg conservative start — ideal for sensitive individuals or first GH peptide cycle
9-1620010Increase to 200 µg if 100 µg well-tolerated

Reconstitution steps

  1. Draw 2.5 mL bacteriostatic water into a 3 mL syringe; inject slowly down the vial wall.
  2. Swirl gently until the lyophilized powder fully dissolves (1–2 minutes); do not shake.
  3. Final concentration: 2 mg/mL (2,000 µg/mL). At this concentration, 1 unit on a U-100 syringe = 20 µg.
  4. Label with date and concentration; refrigerate at 2–8 °C. Use within 20 days (based on 25 doses × 200 µg from 5 mg vial).

Supplies needed

8-week plan

  • 1 vial
  • 56 syringes
  • 3 mL bac water
  • 56 alcohol swabs

12-week plan

  • 2 vials
  • 84 syringes
  • 5 mL bac water
  • 84 alcohol swabs
Need clinics? See vetted providers →

Protocol overview & cycle notes

Restore physiological GH pulsatility through GHRH receptor stimulation with nightly sermorelin injections, targeting improved body composition, recovery, and sleep quality over a 12-week cycle.

Cycle length: 12 weeks on.

Off-cycle: 4–6 weeks off after every 12-week cycle; reassess IGF-1 levels before restarting.

Storage & handling

Lyophilized: store below 25 °C. Reconstituted at 2 mg/mL: refrigerate 2–8 °C; use within 20–28 days. Do not freeze. Inject sermorelin 30–60 minutes before sleep to coincide with natural nocturnal GH pulse.

Injection & tracking tips

  • Inject subcutaneously 30–60 minutes before sleep — sermorelin acts on the hypothalamic-pituitary axis; endogenous GH pulsatility peaks during early sleep stages (NREM Stage 3).
  • Avoid food or high blood glucose for 2 hours before injecting; elevated insulin blunts GH secretion.
  • If combining with a GHRP (ipamorelin, GHRP-2), inject both at the same time from separate syringes at adjacent sites.

Tracking

Logging helps you and your provider spot patterns and adjust dose or timing.

  • Measure IGF-1 serum level at baseline, 6 weeks, and 12 weeks to quantify GH axis response.
  • Track sleep quality (subjective 0–10 and wearable deep sleep duration) — sermorelin typically improves delta-wave sleep within 4–6 weeks.
  • Record body composition changes (waist circumference, lean mass via InBody) every 8 weeks.
Log your cycle in the calculator →

How this works & references

Sermorelin acetate (GHRH 1-29 NH2) is a 29-amino acid analogue of endogenous growth hormone-releasing hormone (GHRH) that binds pituitary GHRH receptors with high affinity, stimulating pulsatile GH release through a physiological mechanism rather than direct GH administration. Unlike exogenous HGH, sermorelin preserves hypothalamic-pituitary-somatotroph feedback, preventing receptor downregulation. Clinical studies from the GHRH-secretagogue literature (Vittone et al., 1997; Walker et al., 1995) demonstrated 30–50% increases in IGF-1 after 12 weeks of nightly sermorelin 500 µg in GH-deficient adults.

Frequently asked questions

Why inject sermorelin before bed?
Growth hormone secretion follows a circadian rhythm with the largest natural pulse occurring 1–2 hours after sleep onset (NREM Stage 3). Sermorelin injection 30–60 minutes before bed primes pituitary somatotrophs to amplify this natural nocturnal pulse, producing higher GH peaks than daytime injection.
Should I combine sermorelin with a GHRP?
Most GH optimization protocols combine sermorelin (GHRH analogue) with ipamorelin or GHRP-2 (ghrelin receptor agonists). The combination stimulates GH release through two independent receptor pathways, producing synergistic secretion approximately 2–4x greater than either peptide alone.
How long before I see results from sermorelin?
IGF-1 levels typically rise within 4–6 weeks. Body composition changes (reduced body fat, improved lean mass) usually become noticeable at 8–12 weeks. Sleep quality improvements are often reported within 2–4 weeks at doses of 200+ µg nightly.
Is sermorelin FDA-approved?
Sermorelin (Geref) was previously FDA-approved for pediatric GH deficiency but was voluntarily withdrawn from the US market in 2008 by the manufacturer. Compounded sermorelin is available through licensed compounding pharmacies and widely used in anti-aging and hormonal optimization medicine.
Can I use sermorelin long-term without a break?
A 4–6 week off-cycle after every 12 weeks is recommended to prevent pituitary desensitization and maintain responsiveness. Check IGF-1 levels during the off-cycle to assess residual GH axis activation before resuming.

Related protocols

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide therapy. Dosing and protocols may vary by formulation and prescriber.